News

Mylan‘s net earnings were $146.99m, compared to $86.93m for the same period in the prior year. The company has posted earnings from operations as $280.47m for the second

Genedata Expressionist for MS processes large experimental data sets of GC- and LC-MS (/MS), labeled and unlabeled – regardless of data formats. Each technology workflow requires specific pre-processing

The company has bought a 16mm and an 18mm Leistritz twin screw extruders. With this new HME, the company is now eligible to conduct feasibility studies by using

Dr Reddy’s Gemcitabine for Injection is the generic version of a cancer medication, Gemzar. Gemzar is indicated as a treatment for cancers of the pancreas, lung and breast

With this license extension application, the company is seeking marketing approval from the EMA for Zonegran as a monotherapy for patients suffering from epilepsy with partial seizures, with

The partnership allows INC to conduct research work on Debiopharm’s drug development project with the management of a clinical study. The partnership further agrees that the Debiopharm’s future

The study of two drugs which are mixed sigma-1 agonists are designed to assess their anti-amnesic and neuroprotective effects. The study includes a model to which oligomeric amyloid

PBS’ single-use bioreactors will be used for R&D and production by the Korean firms. PBS’ bioreactors, which employ a low shear Air Wheel mixing mechanism, are utilized to

Presently, the drug is being under investigation in a Phase II SHELTER study as a second-line treatment for advanced hepatocellular carcinoma and in SAPHIRE Phase II study, as